Sign up to save your podcasts
Or
Share Quantum Leap: IBM & QC Ware Revolutionize Drug Discovery | The Quantum Stack Weekly
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Quantum Leap: IBM & QC Ware Revolutionize Drug Discovery | The Quantum Stack Weekly
This is your The Quantum Stack Weekly podcast.
The Quantum Stack Weekly—your go-to for all things quantum, and today is big. Just within the last 24 hours, IBM and QC Ware announced a breakthrough that could reshape pharmaceutical research.
At the IBM Quantum Summit in Zurich, QC Ware revealed they’ve successfully used a quantum-classical hybrid algorithm to simulate molecular interactions with a precision never seen before. Researchers applied this to protein-ligand binding simulations, a crucial step in drug discovery. Here’s why this matters: Classical computers struggle with these calculations because the complexity scales exponentially with molecular size. Current methods rely on approximations and heuristics, which slow down the identification of viable drug candidates.
But QC Ware’s quantum-enhanced approach, running on IBM’s latest 127-qubit Eagle processor, accelerates these simulations while boosting accuracy. They demonstrated this by modeling how a promising antiviral compound binds to its target protein in record time. The result? Potential drug candidates can be screened far faster and with fewer costly lab experiments. This isn't just theoretical—Pfizer is already collaborating with QC Ware to integrate this into their R&D pipeline.
This leap forward is made possible by advancements in error mitigation and hybrid quantum-classical workflows. IBM’s dynamic circuit techniques allow qubits to recalibrate mid-computation, reducing noise-related errors by nearly 40%. That’s key because quantum speed is meaningless without reliability. And here’s the kicker: This solution is running on near-term quantum hardware, not some distant fault-tolerant system.
But pharmaceuticals aren’t the only space seeing quantum gains. Over at Google Quantum AI, researchers have refined their quantum Monte Carlo algorithms, drastically improving financial risk modeling. Credit Suisse is already testing this for real-world portfolio optimization. Meanwhile, ETH Zurich just published a breakthrough on quantum-enhanced machine learning models, which could supercharge AI training efficiency.
It’s clear: Quantum computing isn’t a hypothetical future anymore. It’s actively solving problems that classical systems cannot handle efficiently. As hardware improves and error rates drop, expect quantum to become indispensable across industries. Stay tuned—The Quantum Stack Weekly will keep you updated on what’s next.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta
The Quantum Stack Weekly—your go-to for all things quantum, and today is big. Just within the last 24 hours, IBM and QC Ware announced a breakthrough that could reshape pharmaceutical research.
At the IBM Quantum Summit in Zurich, QC Ware revealed they’ve successfully used a quantum-classical hybrid algorithm to simulate molecular interactions with a precision never seen before. Researchers applied this to protein-ligand binding simulations, a crucial step in drug discovery. Here’s why this matters: Classical computers struggle with these calculations because the complexity scales exponentially with molecular size. Current methods rely on approximations and heuristics, which slow down the identification of viable drug candidates.
But QC Ware’s quantum-enhanced approach, running on IBM’s latest 127-qubit Eagle processor, accelerates these simulations while boosting accuracy. They demonstrated this by modeling how a promising antiviral compound binds to its target protein in record time. The result? Potential drug candidates can be screened far faster and with fewer costly lab experiments. This isn't just theoretical—Pfizer is already collaborating with QC Ware to integrate this into their R&D pipeline.
This leap forward is made possible by advancements in error mitigation and hybrid quantum-classical workflows. IBM’s dynamic circuit techniques allow qubits to recalibrate mid-computation, reducing noise-related errors by nearly 40%. That’s key because quantum speed is meaningless without reliability. And here’s the kicker: This solution is running on near-term quantum hardware, not some distant fault-tolerant system.
But pharmaceuticals aren’t the only space seeing quantum gains. Over at Google Quantum AI, researchers have refined their quantum Monte Carlo algorithms, drastically improving financial risk modeling. Credit Suisse is already testing this for real-world portfolio optimization. Meanwhile, ETH Zurich just published a breakthrough on quantum-enhanced machine learning models, which could supercharge AI training efficiency.
It’s clear: Quantum computing isn’t a hypothetical future anymore. It’s actively solving problems that classical systems cannot handle efficiently. As hardware improves and error rates drop, expect quantum to become indispensable across industries. Stay tuned—The Quantum Stack Weekly will keep you updated on what’s next.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta
View all episodes
By Quiet. PleaseThis is your The Quantum Stack Weekly podcast.
The Quantum Stack Weekly—your go-to for all things quantum, and today is big. Just within the last 24 hours, IBM and QC Ware announced a breakthrough that could reshape pharmaceutical research.
At the IBM Quantum Summit in Zurich, QC Ware revealed they’ve successfully used a quantum-classical hybrid algorithm to simulate molecular interactions with a precision never seen before. Researchers applied this to protein-ligand binding simulations, a crucial step in drug discovery. Here’s why this matters: Classical computers struggle with these calculations because the complexity scales exponentially with molecular size. Current methods rely on approximations and heuristics, which slow down the identification of viable drug candidates.
But QC Ware’s quantum-enhanced approach, running on IBM’s latest 127-qubit Eagle processor, accelerates these simulations while boosting accuracy. They demonstrated this by modeling how a promising antiviral compound binds to its target protein in record time. The result? Potential drug candidates can be screened far faster and with fewer costly lab experiments. This isn't just theoretical—Pfizer is already collaborating with QC Ware to integrate this into their R&D pipeline.
This leap forward is made possible by advancements in error mitigation and hybrid quantum-classical workflows. IBM’s dynamic circuit techniques allow qubits to recalibrate mid-computation, reducing noise-related errors by nearly 40%. That’s key because quantum speed is meaningless without reliability. And here’s the kicker: This solution is running on near-term quantum hardware, not some distant fault-tolerant system.
But pharmaceuticals aren’t the only space seeing quantum gains. Over at Google Quantum AI, researchers have refined their quantum Monte Carlo algorithms, drastically improving financial risk modeling. Credit Suisse is already testing this for real-world portfolio optimization. Meanwhile, ETH Zurich just published a breakthrough on quantum-enhanced machine learning models, which could supercharge AI training efficiency.
It’s clear: Quantum computing isn’t a hypothetical future anymore. It’s actively solving problems that classical systems cannot handle efficiently. As hardware improves and error rates drop, expect quantum to become indispensable across industries. Stay tuned—The Quantum Stack Weekly will keep you updated on what’s next.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta
The Quantum Stack Weekly—your go-to for all things quantum, and today is big. Just within the last 24 hours, IBM and QC Ware announced a breakthrough that could reshape pharmaceutical research.
At the IBM Quantum Summit in Zurich, QC Ware revealed they’ve successfully used a quantum-classical hybrid algorithm to simulate molecular interactions with a precision never seen before. Researchers applied this to protein-ligand binding simulations, a crucial step in drug discovery. Here’s why this matters: Classical computers struggle with these calculations because the complexity scales exponentially with molecular size. Current methods rely on approximations and heuristics, which slow down the identification of viable drug candidates.
But QC Ware’s quantum-enhanced approach, running on IBM’s latest 127-qubit Eagle processor, accelerates these simulations while boosting accuracy. They demonstrated this by modeling how a promising antiviral compound binds to its target protein in record time. The result? Potential drug candidates can be screened far faster and with fewer costly lab experiments. This isn't just theoretical—Pfizer is already collaborating with QC Ware to integrate this into their R&D pipeline.
This leap forward is made possible by advancements in error mitigation and hybrid quantum-classical workflows. IBM’s dynamic circuit techniques allow qubits to recalibrate mid-computation, reducing noise-related errors by nearly 40%. That’s key because quantum speed is meaningless without reliability. And here’s the kicker: This solution is running on near-term quantum hardware, not some distant fault-tolerant system.
But pharmaceuticals aren’t the only space seeing quantum gains. Over at Google Quantum AI, researchers have refined their quantum Monte Carlo algorithms, drastically improving financial risk modeling. Credit Suisse is already testing this for real-world portfolio optimization. Meanwhile, ETH Zurich just published a breakthrough on quantum-enhanced machine learning models, which could supercharge AI training efficiency.
It’s clear: Quantum computing isn’t a hypothetical future anymore. It’s actively solving problems that classical systems cannot handle efficiently. As hardware improves and error rates drop, expect quantum to become indispensable across industries. Stay tuned—The Quantum Stack Weekly will keep you updated on what’s next.
For more http://www.quietplease.ai
Get the best deals https://amzn.to/3ODvOta